Clinical Trial Update: Determination of Biological Activity of Three Allergen Extracts [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the biological activity of three allergen extracts for hypersensitivity; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypersensitivity

Drugs mentioned

• Allergen extract (three extracts)

Snippet

Sponsor: Roxall Medicina España S.A | Conditions: Hypersensitivity | Phase 2 | Status: COMPLETED